Fox Foundation for Parkinson's Research: Therapeutics Development Initiative

Funding mechanism to support and stimulate preclinical Parkinson’s disease research at for-profit institutions. Part of our annual Pipeline Programs, this funding program seeks to support preclinical development of Parkinson’s disease therapies which have the potential for fundamentally altering disease course and/or improving treatment of symptoms above and beyond current standards of care. Proposals must focus on key and critical preclinical studies necessary for developing, optimizing and evaluating therapeutic strategies that, if successful, can move into human testing. Funding: no budget limit. Only for 2 years. The maximum base salary for an individual applying to an MJFF funding program is $200K.